ArticleScience translational medicine2020

PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity.

Hyungsoo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.